NMRA: Neumora Therapeutics, Inc. Stock

by  •  • Comments Off on NMRA: Neumora Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,979.69
Enterprise Value ($M) 1,796.77
Book Value ($M) 424.54
Book Value / Share 2.66
Price / Book 4.66
NCAV ($M) 417.12
NCAV / Share 2.61
Price / NCAV 4.75

Profitability (mra)
Return on Invested Capital (ROIC) -0.59
Return on Assets (ROA) -0.71
Return on Equity (ROE) -0.77

Liquidity (mrq)
Quick Ratio 17.99
Current Ratio 17.99

Balance Sheet (mrq) ($M)
Current Assets 442.79
Assets 450.21
Liabilities 25.67
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -188.19
Net Income -235.93
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -163.28
Cash from Investing 64.39
Cash from Financing 231.94

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Berns Paul L 5.20
02-13 13G Softbank Group Corp 5.00
12-15 13D/A ARCH Venture Fund XII, L.P. 20.90 7.28
09-27 13D Amgen Inc 23.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-07 10-K Form 10-K
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 56,456 319,492 17.67
2024-07-25 87,552 420,719 20.81
2024-07-24 69,260 386,797 17.91
2024-07-23 71,317 781,470 9.13
2024-07-22 76,214 466,863 16.32

(click for more detail)

Similar Companies
NBIX – Neurocrine Biosciences, Inc. NEOG – Neogen Corporation
NKTX – Nkarta, Inc. NUVL – Nuvalent, Inc.
NVAX – Novavax, Inc.


Financial data and stock pages provided by
Fintel.io